Recent HOOK News
- Form 8-K - Current report • Edgar (US Regulatory) • 07/26/2024 08:08:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/24/2024 08:17:16 PM
- HOOKIPA Pharma Announces Leadership Changes to Intensify Focus on HB-200 • GlobeNewswire Inc. • 07/22/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2024 11:00:16 AM
- HOOKIPA Pharma Announces Effective Date of 1-for-10 Reverse Stock Split • GlobeNewswire Inc. • 07/08/2024 11:01:00 AM
- HOOKIPA Pharma Announces First Person Dosed in Phase 1b Clinical Trial of HB-500 for the Treatment of HIV • GlobeNewswire Inc. • 07/01/2024 08:31:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 08:15:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 08:15:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 08:15:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 08:15:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/18/2024 08:03:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 08:15:13 PM
- HOOKIPA Pharma Announces Updated Phase 2 Clinical Data at the American Society of Clinical Oncology 2024 Annual Meeting • GlobeNewswire Inc. • 06/04/2024 05:00:44 PM
- HOOKIPA Pharma to Host Investor Call on HB-200 Data Presented at American Society of Clinical Oncology 2024 Annual Meeting • GlobeNewswire Inc. • 05/30/2024 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 09:05:13 PM
- HOOKIPA Pharma Announces Positive Clinical Data to be Presented at the American Society for Clinical Oncology 2024 Annual Meeting • GlobeNewswire Inc. • 05/23/2024 09:01:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 11:04:49 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 11:03:13 AM
- HOOKIPA Pharma Reports First Quarter 2024 Financial Results and Recent Business Highlights • GlobeNewswire Inc. • 05/09/2024 11:01:00 AM
- HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab • GlobeNewswire Inc. • 04/25/2024 11:01:00 AM
- HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-700 for the Treatment of KRAS-Mutated Cancers • GlobeNewswire Inc. • 04/24/2024 11:01:00 AM
- HOOKIPA Pharma Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 04/16/2024 08:30:00 PM
- HOOKIPA Pharma to Host Investor Call on HB-200 and Planned Path to Registration • GlobeNewswire Inc. • 04/10/2024 11:01:00 AM
- HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights • GlobeNewswire Inc. • 03/22/2024 11:01:00 AM
- HOOKIPA Pharma to Participate in Leerink Partners Global Biopharma Conference • GlobeNewswire Inc. • 03/06/2024 12:01:00 PM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM